Consistent with these results, mGluR-LTD at CA1 synapses was stronger in Fmr1 knock-out mice and was not responsive to rapamycin treatment, suggesting mTOR deregulation in FXS, which interferes with mGluRs activity and synaptic plasticity [29]. The gene discussed is FMR1; the disease is fragile X syndrome.